Your session is about to expire
← Back to Search
MAP to Health for Sedentary Lifestyle (MAP Trial)
N/A
Waitlist Available
Led By Stephanie Hooker, PhD
Research Sponsored by HealthPartners Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
MAP Trial Summary
This trial is testing a new way to get people to be more active, called MAP to Health. They will be testing how well it works and if it is related to changes in behavior that make people more likely to be active.
MAP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Autonomous Motivation
Basic Psychological Needs Satisfaction
Meaning Salience
+1 moreSecondary outcome measures
Autonomous motivation (Behavioral Regulations in Exercise Questionnaire - 4; BREQ-4)
Basic need satisfaction (Psychological Needs Satisfaction in Exercise Scale)
MAP Trial Design
1Treatment groups
Experimental Treatment
Group I: Intervention development and testingExperimental Treatment1 Intervention
Phase 1 participants (N=12) will complete the MAP to Health online interview and rate the ease of use, usefulness, intention to use, and theoretical fidelity of the intervention.
Phase 2 participants (N=35) will participate in a proof-of-concept pilot trial via a double-pretest single group design. Participants will complete a 4-week pretest monitoring period and an 8-week pilot trial of the intervention, with assessments of Self-Determination Theory mechanisms and meaning salience at pretest (-4 weeks), baseline (0 weeks), midpoint (4 weeks) and posttest (8 weeks). In addition, participants will wear accelerometers to assess physical activity during the 12 week period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MAP to Health
2022
N/A
~40
Find a Location
Who is running the clinical trial?
HealthPartners InstituteLead Sponsor
186 Previous Clinical Trials
3,661,407 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,693 Previous Clinical Trials
28,027,223 Total Patients Enrolled
19 Trials studying Sedentary Lifestyle
4,202 Patients Enrolled for Sedentary Lifestyle
Stephanie Hooker, PhDPrincipal InvestigatorHealthPartners Institute
1 Previous Clinical Trials
88 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger